ACORDA THERAPEUTICS INC 4
4 · ACORDA THERAPEUTICS INC · Filed Sep 23, 2015
Insider Transaction Report
Form 4
Blight Andrew
Chief Scientifc Officer
Transactions
- Exercise/Conversion
Common Stock
2015-09-21$6.00/sh+13,085$78,510→ 84,744 total - Sale
Common Stock
2015-09-21$31.81/sh−6,191$196,966→ 71,659 total - Sale
Common Stock
2015-09-21$30.85/sh−6,894$212,646→ 77,850 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-09-21−13,085→ 0 totalExercise: $6.00Exp: 2016-02-15→ Common Stock (13,085 underlying)
Footnotes (4)
- [F1]Exercise and sales pursuant to a 10b5-1 plan. Dr. Blight exercised 13,085 stock options, all of which were due to expire 2/15/2016 unless exercised.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $30.56 to $31.26 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.29 to $32.29 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The shares subject to these options vested in installments and were fully vested on 2/15/2010.